Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Creatine does not cause hair loss.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Age, diabetes, and cardiogenic shock at PCI are key factors linked to in-hospital death in STEMI patients with hypertension.

Gefitinib can cause scalp skin issues and permanent hair loss.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

More research is needed on better diagnostics, survivorship, and the impact of genetic mutations in lung cancer.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

Normal skin results from interactions between EGF and the Tabby mutation.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Activated erbB-2 in mice skin causes severe skin and hair abnormalities.

Mutant stem cells adapt their metabolism differently to outcompete normal cells in the skin.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

EGF signaling affects gene expression in skin cells, influencing hair growth and potentially cancer.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Antizyme reduces tumor growth and normalizes skin cell development affected by MEK.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Lack of KSR1 stops certain skin tumors in mice.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

ErbB2 signaling is crucial for skin cell growth and cancer development in mice.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

The risk of skin tumors becoming malignant depends on the specific skin cell type affected.

CXCR2 in skin cells promotes tumor growth.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.